Amarin Corp Plcuk (AMRN) EBT Margin (2013 - 2026)

Amarin Corp Plcuk (AMRN) reported EBT Margin of 19.33% for Q1 2026, up 1311.0% year-over-year from 1.37% in Q1 2025, and down 1016.54% quarter-over-quarter from 1.73% in Q4 2025.

Amarin Corp Plcuk (AMRN) EBT Margin (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 14 years of EBT Margin data on file, last reported at 19.33% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 19.33%, up 1311.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.37% (down 958.0% YoY), and the FY2025 annual result was 16.87%, down 1456.0% from the prior year.
  • EBT Margin eased to 19.33% in Q1 2026 per AMRN's latest filing, from 1.73% in the prior quarter.
  • Over five years, EBT Margin peaked at 113.46% in Q4 2022 and troughed at 68.61% in Q2 2022.
  • A 5-year average of 10.31% and a median of 16.86% in 2023 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 10211 bps in 2022, then slumped 11674 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 113.46% in 2022, then plunged by 103 bps to 3.28% in 2023, then jumped by 1178 bps to 35.32% in 2024, then tumbled by 105 bps to 1.73% in 2025, then plunged by 1017 bps to 19.33% in 2026.
  • Business Quant data shows AMRN's EBT Margin at 19.33% in Q1 2026, 1.73% in Q4 2025, and 16.34% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 28.10%
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 44.70%
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 24.89%
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 6.93%
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -21.49%
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 24.18%
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 37.07%
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 135.53%
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 28.20%
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -19.33%

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.33%
Dec 31, 2025 -1.73%
Sep 30, 2025 -16.34%
Jun 30, 2025 -18.49%
Mar 31, 2025 -32.44%
Dec 31, 2024 35.32%
Sep 30, 2024 -50.90%
Jun 30, 2024 4.29%
Mar 31, 2024 -15.31%
Dec 31, 2023 -3.28%
Sep 30, 2023 -28.48%
Jun 30, 2023 -22.35%
Mar 31, 2023 -16.86%
Dec 31, 2022 113.46%
Sep 30, 2022 -4.32%
Jun 30, 2022 -68.61%
Mar 31, 2022 -29.96%
Dec 31, 2021 11.35%
Sep 30, 2021 -9.13%
Jun 30, 2021 5.74%